title: Visual recovery following Mycobacterium chelonae endophthalmitis.
abstract: Following uncomplicated cataract surgery, a patient receiving etanercept for psoriatic arthritis developed Mycobacterium chelonae endophthalmitis. Vitrectomy, capsulectomy, and intraocular lens removal was followed by intravitreal amikacin, topical gatifloxacin, intravenous imipenem, and oral clarithromycin for six months. The patient achieved a final corrected visual acuity of 20/20. Etanercept has been implicated in the development of numerous, severe granulomatous infections, though not previously with M. chelonae. This represents the first reported case of visual recovery following M. chelonae endophthalmitis.
authors.affiliation: Department of Ophthalmology, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA. stewart.michael@mayo.edu
authors.forename: Michael W
authors.initials: MW
authors.lastname: Stewart
authors.forename: Salvador
authors.initials: S
authors.lastname: Alvarez
authors.forename: William W
authors.initials: WW
authors.lastname: Ginsburg
authors.forename: Rajesh
authors.initials: R
authors.lastname: Shetty
authors.forename: Walter C
authors.initials: WC
authors.lastname: McLain
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Sleater
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D009877:Endophthalmitis / Q000382:microbiology / Q000503:physiopathology* / Q000628:therapy; D015818:Eye Infections, Bacterial / Q000382:microbiology / Q000503:physiopathology* / Q000628:therapy; D005500:Follow-Up Studies; D006801:Humans; D007908:Lens, Crystalline / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000382:microbiology / Q000503:physiopathology* / Q000628:therapy; D016926:Mycobacterium chelonae / Q000302:isolation & purification*; D020127:Recovery of Function / Q000502:physiology*; D014792:Visual Acuity / Q000502:physiology*; D014821:Vitrectomy
chemical_list: D000900:Anti-Bacterial Agents